These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35640714)

  • 1. Epigenetic regulation of cancer stem cells: Shedding light on the refractory/relapsed cancers.
    Xu L; Zhang J; Sun J; Hou K; Yang C; Guo Y; Liu X; Kalvakolanu DV; Zhang L; Guo B
    Biochem Pharmacol; 2022 Aug; 202():115110. PubMed ID: 35640714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
    Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
    Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic targeting of cancer stem cells by polyphenols (cancer stem cells targeting).
    Ghasemi S; Xu S; Nabavi SM; Amirkhani MA; Sureda A; Tejada S; Lorigooini Z
    Phytother Res; 2021 Jul; 35(7):3649-3664. PubMed ID: 33619811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs.
    Menendez JA
    Curr Pharm Des; 2015; 21(25):3644-53. PubMed ID: 26166605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autophagy in the maintenance and function of cancer stem cells.
    Vitale I; Manic G; Dandrea V; De Maria R
    Int J Dev Biol; 2015; 59(1-3):95-108. PubMed ID: 26374531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.
    Issa ME; Takhsha FS; Chirumamilla CS; Perez-Novo C; Vanden Berghe W; Cuendet M
    Clin Epigenetics; 2017; 9():17. PubMed ID: 28203307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Stem Cells: An Ever-Hiding Foe.
    Wilczyński JR
    Exp Suppl; 2022; 113():219-251. PubMed ID: 35165866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic alterations involved in cancer stem cell reprogramming.
    Muñoz P; Iliou MS; Esteller M
    Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.
    Ma Z; Wang YY; Xin HW; Wang L; Arfuso F; Dharmarajan A; Kumar AP; Wang H; Tang FR; Warrier S; Tergaonkar V; Sethi G
    Int J Biochem Cell Biol; 2019 Mar; 108():17-20. PubMed ID: 30630112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
    Lee SH; Reed-Newman T; Anant S; Ramasamy TS
    Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics.
    Tandon I; Waghmode A; Sharma NK
    Curr Cancer Drug Targets; 2019; 19(11):877-884. PubMed ID: 31393247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
    Easwaran H; Tsai HC; Baylin SB
    Mol Cell; 2014 Jun; 54(5):716-27. PubMed ID: 24905005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
    Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
    Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
    Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
    Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the epigenetic origin of cancer stem cells.
    Vincent A; Van Seuningen I
    Biochim Biophys Acta; 2012 Aug; 1826(1):83-8. PubMed ID: 22495062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.